Sylvain Sachot is a highly accomplished professional with expertise in the biotechnology and investment sectors. Sachot received a Master of Business Administration (MBA) in Business Administration and Management from Esade as well as a PhD in Biology, Biochemistry, and Molecular Biology from the University of Nantes. Additionally, Sachot holds a Master's degree in Biotechnology from the Université Paris - Val-de-Marne (Paris XII). Sachot has held multiple leadership and investment roles, including Principal at Asabys Partners and Investment Director at Ysios Capital. Sachot has also served as a Board Director and Observer for companies such as Anaconda BioMed, Splice Bio, MedLumics, S.L., and INBRAIN Neuroelectronics. Prior to investing, Sachot worked as a Postdoctoral Researcher at the Icahn School of Medicine at Mount Sinai and a Business Analyst at Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de Recerca. Overall, Sachot's extensive experience in biotechnology, investments, and leadership make him a highly sought-after professional in the industry.